• Skip to primary navigation
  • Skip to main content
ASC Therapeutics

ASC Therapeutics

Genes and Cells for Cure

  • About Us
    • Our Team
    • Hemophilia Advisory Board
    • Cell Therapy Advisory Board
  • Our Technology
  • Focus
    • Gene Therapy
    • Stem Cell Therapy
  • Our Pipeline
  • Our Partners
  • Investors
    • Investors
    • Releases
  • News
    • Publications
    • Industry News
    • Company News

Investors

Hermed Capital

Hermed Capital Fund (the “Fund”) is a private equity fund that will invest primarily in healthcare industry around the world.

Fosun International

Fosun International Limited is a technology-driven consumer group that has been listed on the main board of the Hong Kong Stock Exchange (00656.HK) since 2007.

Advantech Capital

Launched in January 2016 by Mr. Jianming Yu, Advantech Capital is a private equity fund, focused on innovation-driven growth capital in China.

Ping An Group

Ping An of China is devoted to becoming a world-leading personal financial services provider.

Simcere

Simcere Pharmaceutical Group is China's leading R&D-driven pharmaceutical company. It has been ranked amongst the top 100 pharmaceutical companies in China and in the top 10 of the most innovative pharmaceutical companies in China for several consecutive years. Simcere was the first Chinese biological and chemical pharmaceutical company to be listed on the New York Stock Exchange.

IRS Form 8937

ASC-International-Form-8937
ASC-International-Form-8937-7.6.2020
Form-8937-Attachment-ASC

Form-8937-Attachment-ASC-7.6.2020

Copyright © 2021 ASC Therapeutics

This website uses cookies to improve your experience. We'll assume you accept this policy as long as you are using this websiteAcceptLearn More